Paraoxonase-gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis?

American Journal of Human Genetics

Volumn 62, Issue 1, 1998, Pages 20-24

  Heinecke, J W ^a   Lusis, A J ^a  

^a Box 8046   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLESTERASE;

CORONARY RISK; DNA POLYMORPHISM; EDITORIAL; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031939725     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301691     Document Type: Editorial

References (26)

1. BN Ames MK Shigenaga TM Hagen Oxidants, antioxidants, and the degenerative disease of aging Proc Natl Acad Sci USA 90 1993 7915 7922
2. M Antikanen S Murtomaki M Syvanne R Pahlman E Tahuanainen M Jauhiainen MH Frick The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns J Clin Investig 98 1996 883 885
3. JA Berliner JW Heinecke The role of oxidized lipoproteins in atherogenesis Free Radic Biol Med 20 1996 707 727
4. M-C Blatter-Garin CA Abbott S Messmer MI Mackness PN Durrington D Pometta RW James Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations Biochem J 304 1994 549 554
5. HG Davies RJ Richter M Keifer CA Broomfield J Sowalla CE Furlong The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin Nat Genet 14 1996 334 336
6. MC Garin RW James P Dussoix H Blanche P Passa P Froguel J Ruiz Paraoxonase polymorphism Met-Leu 54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes J Clin Investig 99 1997 62 66
7. C Hassett RJ Richter R Humbert C Chapline JW Crabb CJ Omiecinski CE Furlong Characterisation of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence Biochemistry 30 1991 10141 10149
8. JW Heinecke Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis Curr Opin Lipid 8 1997 268 274
9. SM Herrmann H Blanc O Poirier D Arveiler G Luc A Evans P Marques-Vidal The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study Atherosclerosis 126 1996 299 303
10. R Humbert DA Adler CM Distecke C Hassett CJ Omiecinski CE Furlong The molecular basis of the human serum paraoxonase activity polymorphism Nat Genet 3 1993 73 76
11. AJ Lusis A Wainsab TA Drake Genetics of atherosclerosis EJ Topol Textbook of cardiovascular medicine 1998 Lippincott-Raven Philadelphia 2389 2413
12. MI Mackness S Arrol PN Durrington Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein FEBS Lett 286 1991 a 152 154
13. MI Mackness D Harty D Bhatnagar PH Winocour S Arrol M Ishola Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Atherosclerosis 86 1991 b 193 199
14. MI Mackness B Mackness PN Durrington PW Connelly RA Hegele Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins Curr Opin Lipid 7 1996 69 76
15. M Navab JA Berliner AD Watson SY Hama MC Territo AJ Lusis DM Shih The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture Arterioscler Thromb Vasc Biol 16 1996 831 842
16. M Navab S Hama-Levy BJ Van Lenten GC Fonarow CJ Cardinez LW Castellani ML Brennan Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio J Clin Invest 99 1997 2005 2019
17. M Odawara Y Tachi K Yamashita Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 82 1997 2257 2260
18. SL Primo-Parmo RC Sorenson J Teiber BN La Du The human serum paroxonase/arylesterase gene (PON1) is one member of a multigene family Genomics 33 1996 498 507
19. J Ruiz H Blanche RW James M-C Blatter-Garin C Vaisse G Charpentier N Cohen Gin-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes Lancet 346 1995 869 872
20. DK Sanghera CE Aston N Saha MI Kamboh DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease Am J Hum Genet 62 1998 36 44 (in this issue)
21. M Serrato AJ Marian A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease J Clin Invest 96 1995 3005 3008
22. DM Shih L Gu S Hama Y-R Xia M Navab AM Fogelman AJ Lusis Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model J Clin Invest 97 1996 1630 1639
23. D Steinberg Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346 1995 36 38
24. NG Stephens A Parsons PM Schofield F Kelly K Cheeseman MJ Mitchinson MJ Brown Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 347 1996 781 786
25. T Suehiro Y Nakauchi M Yamamoto K Arii H Itoh N Hamashige K Hashimoto Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease Int J Cardiol 57 1996 69 73
26. AD Watson JA Berliner SY Hama BN La Du KF Faull AM Fogelman M Navab Protective effect of high-density lipoprotein associated PON: inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891